Vascular risk factors and dementia How to move forward?

被引:323
作者
Viswanathan, Anand [1 ,2 ,3 ]
Rocca, Walter A. [4 ,5 ]
Tzourio, Christophe [6 ,7 ,8 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Clin Trials Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Mayo Clin, Coll Med, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA
[5] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA
[6] Univ Paris 06, F-75252 Paris 05, France
[7] INSERM, Unit Neuroepidemiol 708, Paris, France
[8] Hop Lariboisiere, Dept Neurol, F-75475 Paris, France
关键词
WHITE-MATTER HYPERINTENSITIES; MIDLIFE BLOOD-PRESSURE; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; APOLIPOPROTEIN-E; CEREBROVASCULAR-DISEASE; BRAIN INFARCTS; STROKE; LESIONS; LIFE;
D O I
10.1212/01.wnl.0000341271.90478.8e
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In recent years, accumulating evidence has suggested that vascular risk factors contribute to Alzheimer disease ( AD). Vascular dementia had been traditionally considered secondary to stroke and vascular disease. It has been traditionally distinguished from AD, considered to be a purely neurodegenerative form of dementia. However, in light of this more recent literature, it appears that there is a spectrum: ranging from patients with pure vascular dementia to patients with pure AD and including a large majority of patients with contributions from both Alzheimer and vascular pathologies. In this article, we discuss the impact of vascular risk factors on AD and its consequences at the individual level and at the population level by highlighting the concept of attributable risk. We then discuss the key questions and next steps involved in designing a therapeutic trial to control vascular risk factors for the prevention of dementia. Neurology (R) 2009; 72:368-374
引用
收藏
页码:368 / 374
页数:7
相关论文
共 55 条
[1]  
[Anonymous], 1991, JAMA, V265, P3255
[2]   Silent MRI infarcts and the risk of future stroke - The cardiovascular health study [J].
Bernick, C ;
Kuller, L ;
Dulberg, C ;
Longstreth, WT ;
Manolio, T ;
Beauchamp, N ;
Price, T .
NEUROLOGY, 2001, 57 (07) :1222-1229
[3]   Cognition and diabetes: a lifespan perspective [J].
Biessels, Geert Jan ;
Deary, Ian J. ;
Ryan, Christopher M. .
LANCET NEUROLOGY, 2008, 7 (02) :184-190
[4]   Efficacy and tolerability of donepezil in vascular dementia -: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial [J].
Black, S ;
Román, GC ;
Geldmacher, DS ;
Salloway, S ;
Hecker, J ;
Burns, A ;
Perdomo, C ;
Kumar, D ;
Pratt, R .
STROKE, 2003, 34 (10) :2323-2330
[5]   Forecasting the global burden of Alzheimer's disease [J].
Brookmeyer, Ron ;
Johnson, Elizabeth ;
Ziegler-Graham, Kathryn ;
Arrighi, H. Michael .
ALZHEIMERS & DEMENTIA, 2007, 3 (03) :186-191
[6]   White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients [J].
Burton, EJ ;
Kenny, RA ;
O'Brien, J ;
Stephens, S ;
Bradbury, M ;
Rowan, E ;
Kalaria, R ;
Firbank, M ;
Wesnes, K ;
Ballard, C .
STROKE, 2004, 35 (06) :1270-1275
[7]   CRITERIA FOR THE DIAGNOSIS OF ISCHEMIC VASCULAR DEMENTIA PROPOSED BY THE STATE OF CALIFORNIA ALZHEIMERS-DISEASE-DIAGNOSTIC-AND-TREATMENT-CENTERS [J].
CHUI, HC ;
VICTOROFF, JI ;
MARGOLIN, D ;
JAGUST, W ;
SHANKLE, R ;
KATZMAN, R .
NEUROLOGY, 1992, 42 (03) :473-480
[8]   Cognitive impact of subcortical vascular and Alzheimer's disease pathology [J].
Chui, Helena C. ;
Zarow, Chris ;
Mack, Wendy J. ;
Ellis, William G. ;
Zheng, Ling ;
Jagust, William J. ;
Mungas, Dan ;
Reed, Bruce R. ;
Kramer, Joel H. ;
DeCarli, Charles C. ;
Weiner, Michael W. ;
Vinters, Harry V. .
ANNALS OF NEUROLOGY, 2006, 60 (06) :677-687
[9]  
de Groot JC, 2000, ANN NEUROL, V47, P145
[10]  
de Leeuw FE, 1999, ANN NEUROL, V46, P827, DOI 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.3.CO